Mid-cap Picks with Anil Singhvi: Jay Thakkar picks CCL Products, Andhra Sugars and Strides Pharma for top returns

In a chat with Zee Business Managing Editor Anil Singhvi today, market expert Jay Thakkar recommended his top three mid-cap stock picks for investors to buy, which he said have great potential to earn bumper returns. These stocks were recommended with long-term, positional medium-term, and short-term views. Know why this analyst thinks these stocks hold promise!  

Long Term Pick: CCL Products 

This is the second time within a month, the market analyst Jay Thakkar has recommended this stock - CCL Products. Thakkar had earlier suggested this stock on March 26, 2021, for short-term buy. The stock has reported a growth of between 8-10 per cent since then. This time, the expert chose CCL Products for long-term gains with an aggressive target of Rs 400 per share and stop-loss of Rs 210 apiece; risk-reward 1:4.  

See Zee Business Live TV Streaming Below:

Thakkar explains, there has been a consolidation seen in the stock for over six months and the correction is come to end in the stock. He adds, the short-term indicators are also coming into the picture with a long-term momentum. 

Positional Pick: Andhra Sugars 

In this mid-cap stock, a spectacular breakout can be seen and a symmetrical triangle pattern has been also formed, moreover, there has also been increase in volumes of this stock, Thakkar explains. He adds, in the last two days, we see a breakout with respect to volumes, which clearly indicates a price volume breakout in this stock.  

निवेश शॉर्ट टर्म हो या पोजीशनल या लॉन्ग टर्म... किन मिडकैप शेयरों में बनेगा पैसा?

जय ठक्कर से जानिए दमदार फंडामेंटल वाले 3 बेहतरीन मिडकैप स्टॉक्स#SPLMidcapStocks #StockMarket @AnilSinghvi_ @JayThakkar22 pic.twitter.com/PIjHGkJ7Wr

— Zee Business (@ZeeBusiness) April 16, 2021

As for indicators of short and mid-term have clearly given by crossover, Thakkar recommends to buy this stock with a target of Rs 465 per equity in a positional category. He also sets a stop-loss of Rs 310 per share, here too the risk-reward 1:4. He affirms, this breakout is visible after a really long time. 

Short Term Pick: Strides Pharma

On Strides Pharma, which is trading at Rs 883 per share, the market expert has set a short-term target of Rs 1010 per share, with a stop-loss of Rs 813 apiece. He explains, this stock slowly and gradually is in a higher top, higher bottom uptrend. Moreover, it is already in upward sloping channel trade.